Latest Capital Raising And Funding News

Impact Minerals has reported standout assays from the first two holes in its Commonwealth JV drilling program, confirming rich gold, silver, and base metal mineralisation that extends known zones and sets the stage for an expanded Phase II campaign.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

Cooper Metals has swapped its Oorindi Project for the Pyramid Gold Project in North Queensland, a high-grade gold asset in the prolific Drummond Basin. The company plans immediate exploration and a $979,500 capital raise to fund drilling and technical expansion.

Great Divide Mining has transitioned its Challenger Gold Mine in NSW from commissioning to commercial production, targeting a gold concentrate grade of 30 grams per tonne from historic tailings with minimal capital expenditure.

Cosmo Metals is gearing up for a significant drilling campaign at its Kanowna Gold Project near Kalgoorlie, while systematic exploration at its NSW projects has revealed two high-priority copper-gold VMS targets. The company also bolstered its balance sheet with a $1.55 million entitlement offer to fund ongoing work.

AuKing Mining has agreed to acquire the Tundulu Rare Earths Project in Malawi, a large and under-explored carbonatite complex with strong historical drilling results. The acquisition is supported by a $3 million capital raise to fund exploration and drilling activities.

BlinkLab has secured A$17.5 million through an oversubscribed placement to fuel regulatory trials and commercial launch of its AI-driven autism and ADHD diagnostic tools.

Core Energy Minerals (ASX:CR3) has revealed significant rare earth element mineralisation at its Cummins Project in South Australia, highlighting broad zones of high-grade TREO with promising magnet rare earth oxide ratios and potential for in-situ recovery mining.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing of its investigational drug PYC-001 for Autosomal Dominant Optic Atrophy from single to multiple doses, marking a key step in its clinical development.

Hiremii Limited has landed its initial paying customers for its AI-powered workforce intelligence platform, marking a pivotal step in its shift from recruitment services to a SaaS technology provider in energy and infrastructure sectors.

Talius Group has inked a Master Services Agreement with Adventist Retirement Plus to roll out its Nurse Call and Sleep Systems across two Queensland villages, setting the stage for wider expansion and recurring revenue growth.

Jindalee Lithium Limited's US subsidiary, HiTech Minerals, has signed a binding agreement with Constellation Acquisition Corp I to form US Elemental Inc., a NASDAQ-listed company holding the McDermitt Lithium Project. The transaction values the new entity at approximately US$571 million enterprise value, with Jindalee retaining majority ownership.